Key facts
- Notable investors include Seventure.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for VeCollal
- ·The full record, as it builds
Funding rounds
No funding rounds for VeCollal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VeCollal
Developer of plant-based biomimetic ingredients designed for use in nutraceutical and cosmetic formulations. The company offers collagen alternatives with amino acid profiles identical to human collagen and clinically validated efficacy comparable to marine and bovine sources, enabling ingredient manufacturers and product developers to create high-performance supplements and skincare products with enhanced bioavailability, ethical sourcing, and broad market appeal.
- Sector
- Business Products and Services (B2B)
- HQ
- Belgium
- Founded
- 2020
- Employees
- 3
- Website
- vecollal.eu/
- Ownership
- Privately Held (backing)
VeCollal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VeCollal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VeCollal in its N-PORT filings yet. We sweep new filings monthly.